Headline
The latest stories from AHA Today.
The Food and Drug Administration authorized for emergency use an armband device that screens people without COVID-19 symptoms for certain potential SARS-CoV-2 biomarkers, such as excessive blood clotting.
AstraZeneca said its AZD1222 COVID-19 vaccine candidate is safe and effective, based on data culled from a phase 3 clinical trial of 32,449 U.S. patients.
The House of Representatives voted 246-175 to approve H.R. 1868, a bill that, among other health care provisions, would eliminate the 2% across-the-board cut to all Medicare payments, known as sequestration, until the end of 2021.
The Food and Drug Administration yesterday updated the health care provider fact sheets for all three monoclonal antibody therapies authorized for emergency use to include information on whether SARS-CoV-2 variants may show resistance to that therapy.
AHA urged the Centers for Medicare & Medicaid Services to extend the five-year window for building medical residency programs to account for the COVID-19 public health emergency.
The Department of Health and Human Services postponed for one year, pending judicial review, a final rule that would require the agency to assess periodically each regulation to determine whether it has a significant economic impact on a substantial number of small entities and, if so, determine…
For the first time, the Food and Drug Administration authorized marketing a SARS-CoV-2 diagnostic test beyond the public health emergency based on additional data. FDA previously authorized the BioFire Respiratory Panel 2.1 test for emergency use to detect SARS-CoV-2 and other respiratory pathogens…
AHA urged the Department of Justice to investigate thoroughly UnitedHealth Group’s proposed acquisition of Change Healthcare because it threatens to reduce competition for the sale of health care information technology services to hospitals and other health care providers.
The Centers for Disease Control and Prevention has created a federal classification scheme for SARS-CoV-2 variants and posted information on their prevalence in the United States.
The Senate voted 50-49 to confirm President Biden’s nomination of Xavier Becerra to be the next Secretary of Health and Human Services.